High Mobility Group Box 1 and Interleukin 6 at Intensive Care Unit Admission as Biomarkers in Critically Ill COVID-19 Patients

Exuberant inflammation manifesting as a “cytokine storm” has been suggested as a central feature in the pathogenesis of severe coronavirus disease 2019 (COVID-19). This study investigated two prognostic biomarkers, the high mobility group box 1 (HMGB1) and interleukin-6 (IL-6), in patients with seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Sivakorn, Chaisith, Dechsanga, Jutamas, Jamjumrus, Lawan, Boonnak, Kobporn, Schultz, Marcus J., Dondorp, Arjen M., Phumratanaprapin, Weerapong, Ratanarat, Ranistha, Naorungroj, Thummaporn, Wattanawinitchai, Patchrapa, Siripoon, Tanaya, Duangdee, Chatnapa, Techarang, Tachpon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274790/
https://www.ncbi.nlm.nih.gov/pubmed/33939645
http://dx.doi.org/10.4269/ajtmh.21-0165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274790/
https://www.ncbi.nlm.nih.gov/pubmed/33939645
http://dx.doi.org/10.4269/ajtmh.21-0165

Ejemplares similares